China News Service, May 24. In a video meeting between the prime ministers of China and Malaysia, China expressed its support for Malaysia to increase its vaccine production capacity.
For this, the Malaysian government and business community highly affirmed and expressed gratitude.
Starting from March 18, Malaysia began to vaccinate the new crown vaccine produced by China Kexing Biotechnology. The Minister of Science, Technology and Innovation of Malaysia, Kyri Jamaluddin, became the first recipient of Kexing's new crown vaccine in the country.
Photo by Wen Junqin issued by China News Agency
According to Xinhua News Agency, the prime ministers of the two countries exchanged in-depth views on China-Malaysia relations and cooperation, and international cooperation in the fight against the new crown pneumonia epidemic at the above-mentioned video conference.
China expresses its support for Malaysia to improve its vaccine production capacity, supports the health departments and epidemic prevention experts of the two countries to strengthen exchanges, cooperation and experience sharing, and hopes that Malaysia will ensure that Chinese citizens in Malaysia receive vaccines as soon as possible.
In this regard, Malaysian Prime Minister Muhyiddin recently posted a detailed introduction on his social media Facebook account.
According to a report by Bernama, Muhyiddin pointed out that despite the impact of the epidemic, bilateral relations between Malaysia and China are still developing in a friendly and positive direction. Cooperation projects between the two sides include vaccine production, such as potting the new crown vaccine developed by China in Malaysia.
Muhyiddin also expressed his gratitude to China, because China was the first friendly country to lend a helping hand at the beginning of the country's outbreak of the new crown epidemic.
Malaysian Prime Minister Muhyiddin posted a message on Facebook to thank China for lending a helping hand in the early stages of the epidemic.
Image source: Screenshot of Muhyiddin’s social media account
The Malaysian Chamber of Commerce also welcomes China’s support for Malaysia’s efforts to increase its vaccine production capacity.
The Malaysian Sing State Network reported that the Malaysian Chamber of Commerce believes that this move can be said to be "sending charcoal in the snow" under the current slow progress of vaccination in Malaysia and insufficient supply.
Chen Youxin, President of the Malaysia-China Chamber of Commerce, also stated that in addition to increasing vaccine production capacity and China’s effective anti-epidemic record, “we should establish a special committee with China to strengthen the interactive exchanges between the official agencies and epidemic prevention experts of the two countries, especially in-depth sharing. China’s Anti-epidemic Experience".
On February 27, the first batch of semi-finished products of the new crown vaccine produced by Beijing Kexing Zhongwei Biotechnology Co., Ltd. arrived at Kuala Lumpur International Airport in Malaysia, and was officially delivered to Malaysia's Fama Company.
China News Agency issued a photo courtesy of the Chinese Embassy in Malaysia
As early as February this year, when Malaysia’s first batch of semi-finished products for the new crown vaccine ordered by China Kexing arrived in Kuala Lumpur, Malaysian Foreign Minister Hishamuddin said through social media that Malaysia was able to obtain Kexing’s new crown vaccine. The "strong relationship" between China and China.
The Chinese Ambassador to Malaysia Ouyang Yujing also said at the time that the Chinese and Malaysian governments and peoples are fighting side by side on the two fronts of fighting the epidemic and restoring the economy, and have always given firm support and sincere help to each other, which embodies the deep friendship of sharing weal and woe and helping each other.
It is reported that at present, China has provided vaccine assistance to more than 80 urgently needed developing countries, exported vaccines to 43 countries, and has supplied 300 million doses of vaccine globally.
These vaccines are mainly used to support the majority of developing countries in the fight against the epidemic, and have effectively promoted the availability and affordability of vaccines.